hydromorphone IV
Selected indexed studies
- 2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. (Headache, 2026) [PMID:41321235]
- Prescription of Controlled Substances: Benefits and Risks. (, 2026) [PMID:30726003]
- Investigational Drugs for the Treatment of Postherpetic Neuralgia: Systematic Review of Randomized Controlled Trials. (Int J Mol Sci, 2023) [PMID:37629168]
_Worker-drafted node — pending editorial review._
Connections
hydromorphone IV is a side effect of
Sources
- Prescription of Controlled Substances: Benefits and Risks. (2026) pubmed
- 2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. (2026) pubmed
- Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine. (2017) pubmed
- A randomized study of IV prochlorperazine plus diphenhydramine versus IV hydromorphone for migraine-associated symptoms: A post hoc analysis. (2021) pubmed
- Investigational Drugs for the Treatment of Postherpetic Neuralgia: Systematic Review of Randomized Controlled Trials. (2023) pubmed
- Safety Analysis of IV Methadone vs. IV Hydromorphone in Post-Procedural Adults. (2026) pubmed
- Intraoperative Methadone in Next-day Discharge Outpatient Surgery: A Randomized, Double-blinded, Dose-finding Pilot Study. (2023) pubmed
- Randomized Clinical Trial of Intravenous (IV) Acetaminophen as an Adjunct to IV Hydromorphone for Acute Severe Pain in Emergency Department Patients. (2020) pubmed
- Pharmacokinetics and pharmacodynamics of hydromorphone after intravenous and intramuscular administration in horses. (2020) pubmed
- The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients. (2017) pubmed